Krsnaa Diagnostics Allots ₹430 Crore NCDs to Asian Development Bank
Krsnaa Diagnostics Limited has approved the allotment of 43,000 Non-Convertible Debentures worth ₹430 crore to Asian Development Bank on a private placement basis. These NCDs carry a 7.790% annual interest and have a tenure of 7 years, with redemption starting six months post-allotment.
The debt fundraising of ₹430 crore will provide the company with capital for its operations and potential expansion, impacting its financial leverage and growth prospects.
The company has successfully raised a significant amount of debt financing from a reputable institution like ADB, which indicates financial health and growth potential.
Krsnaa Diagnostics Limited has announced the allotment of 43,000 Unlisted, Secured, Unrated, Redeemable, transferable, Interest bearing Non-Convertible Debentures (NCDs) with a face value of ₹1,00,000 each, aggregating to ₹430 crore. The allotment was made on a private placement basis to Asian Development Bank (ADB).
The decision was approved by the Operation Committee of the Board of Directors at its meeting held on February 23, 2026. The meeting commenced at 14:30 Hrs. (IST) and concluded at 15:00 Hrs. (IST).
The NCDs have a tenure of 7 years from the date of allotment, with a maturity date of February 23, 2033. The coupon/interest offered is 7.790% per annum. The company will redeem the debentures in thirteen equal installments, commencing six months from the allotment date, with interest and principal payable on a half-yearly basis. A charge has been created over identified assets of the Company as security.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under debt fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.